AMICULUM is an independent group of agencies offering value-added services and consultancy to the NHS and medical device, pharmaceutical and biotechnology companies across the globe, with more than 220 healthcare communications specialists and support staff employed in eight locations worldwide. The team comprises scientists and healthcare professionals with backgrounds in medicine and pharmacy, and staff who have experience working in regulatory affairs, medical affairs, medical information, clinical research and marketing, as well as staff with vast experience in the healthcare agency and consulting sectors, and other academic and industry sectors. The company has now launched AMICULUM Access, a full-service market access agency that combines existing in-house market access expertise from across AMICULUM’s agencies to create a consolidated service for existing and new clients.
“a full-service market access agency that combines existing in-house market access expertise from across AMICULUM’s agencies to create a consolidated service“
AMICULUM Access agency lead, Claire Woon, said: “AMICULUM already delivers high-quality market access projects through our medical communications teams, especially in the challenging areas of rare and genetic diseases. The launch of AMICULUM Access means we can support more of this work with a broader range of specialist payer expertise and greater capacity. It’s really exciting to be leading a team working on the complex market access challenges associated with cutting edge pharmaceuticals.”